Archived

This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.

US Patent Number

7300651

Publication Date

11-27-2007

Abstract

The present invention provides methods of delaying development of CEA-associated tumors using the anti-idiotype antibody 3H1, particularly in high-risk individuals.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

10/819,493

Filing Date

04/06/2004

Share

COinS